Hovione´s Rapid Proof of Concept Dry Powder Inhalation Product Development

Hovione announces filing of patent for new powder inhaler

Hovione and Particle Sciences Inc. ink deal to speed up drug solubilization projects

OSHA renews Hovione’s VPP STAR Certification

Top health and safety standards recognized

New Products at Hovione, 6 inspections in 8 months

Loures, Portugal, May 9th, 2011 – Hovione today announced that in the past 8 months the Company has had a large number of GMP inspections

Hovione Wins Flumethasone Patent Case

Hovione’s TwinCaps® dry-powder inhaler approved in Japan as part of Inavir® influenza treatment

Hovione’s sales grow 15%

Sales reach USD 144 million for the fiscal year ended March 31st 2010.

Hovione scientists bring PAT and inhalation expertise to USP

Hovione’s TwinCaps® dry-powder inhaler filed in Japan for the treatment of influenza